Abstract
The intestinal T-cell lymphomas are a rare group of lymphatic malignancies arising from the gastrointestinal tract. They frequently manifest with non-specific clinical and radiographic findings that may mimic several other disease processes. The most common subtype is linked with refractory coeliac disease and commonly affects the small intestine. We report a case where the diagnosis was uncovered endoscopically in a patient presenting with colonic perforation on a background of long-standing ulcerative colitis. Surgical source control was required prior to considering chemotherapy, which is the usual treatment option in lymphatic malignancies. The case highlights the importance endoscopic evaluation in inflammatory conditions of the colon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ondrejka S, Jagadeesh D. Enteropathy-associated T-cell lymphoma. Curr Hematol Malig Rep. 2016;11:504–13.
(IARC) IAfRoC. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer (IARC); 2017
Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148–55.
Sun Z-H, Zhou H-M, Song G-X, et al. Intestinal T-cell lymphomas: a retrospective analysis of 68 cases in China. World J Gastroenterol. 2014;20:296–302.
van de Water JMW, Nijeboer P, de Baaij LR, et al. Surgery in (pre)malignant celiac disease. World J Gastroenterol 2015; 21:12403–12409
Babel N, Paragi P, Chamberlain RS. Management of enteropathy-associated T-cell lymphoma: an algorithmic approach. Case Rep Oncol. 2009;2:36–43.
Cirocchi R, Farinella E, Trastulli S, et al. Surgical treatment of primitive gastro-intestinal lymphomas: a systematic review. World J Surg Oncol. 2011;9:145.
Sampietro GM, Casiraghi S, Foschi D. Perforating Crohn’s disease: conservative and surgical treatment. Dig Dis. 2013;31:218–21.
Overbey D, Govekar H, Gajdos C. Surgical management of colonic perforation due to ulcerative colitis during pregnancy: Report of a case. World J Gastrointestinal Surg. 2014;6:201–3.
Badgwell BD, Camp ER, Feig B, et al. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol. 2008;19:577–82.
Nally DM, Kavanagh DO. Current controversies in the management of diverticulitis: a review. Digestive Surg. 2019;36:195–205.
Kim JB, Kim SH, Cho YK, et al. A case of colon perforation due to enteropathy-associated T-cell lymphoma. World J Gastroenterol. 2013;19:1841–4.
Hsiao CH, Kao HL, Lin MC, et al. Ulcerative colon T-cell lymphoma: an unusual entity mimicking Crohn’s disease and may be associated with fulminant hemophagocytosis. Hepatogastroenterology. 2002;49:950–4.
Tian S, Xiao SY, Chen Q, et al. Monomorphic epitheliotropic intestinal T-cell lymphoma may mimic intestinal inflammatory disorders. Int J Immunopathol Pharmacol. 2019;33:2058738419829387.
Zhang J-C, Wang Y, Wang X-F, et al. Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review. OncoTargets Therapy. 2016;9:863–8.
Lakatos P-L, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008;14:3937–47.
Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma French Coeliac Dis Study Group. Lancet. 2000;356:203–8.
Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13:847–858.e844; quiz e848–850
Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54:1121–5.
Karran P, Attard N. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer. 2008;8:24–36.
Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–25.
Acknowledgements
We would like to thank Dr. Vanita Bhargava for her assistance with the histopathological component of this case report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Ali Mourad, Marie Shella De Robles and Robert Winn declare that they have no conflict of interest.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from the patient for publication of this case study during his time in our unit.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mourad, A.P., De Robles, M.S. & Winn, R.D. Intestinal T-cell lymphoma presenting as colonic perforation in the setting of ulcerative colitis: a case report. Clin J Gastroenterol 14, 176–180 (2021). https://doi.org/10.1007/s12328-020-01279-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-020-01279-1